It has been suggested that RSG, a PPAR‐γ agonist, can drive microglial/macrophage polarization and phenotypic change,27 which is highly dynamic after ischemic injury.10 We next examined whether RSG treatment altered the function and phenotypic change of microglia/macrophage in the tPA‐treated stroke mice. This evidence concerns the gene PLAT and Stroke.